The determination of serum B
12 concentration, unsaturated B
12 binding capacity, separaption of transcobalamin 1 and transcobalamin 11, measurement of endogenous B
12 in transcobalamins and investigation of natural occurrence of B
12 derivatives in serum and transcobaiamins were done on sera from healthy individuals, patients with chronic granulocytic leukemia and acute hepatitis.
Methylcobalamin (CH
3-B
12) in serum and transcobalamin 1 from healthy individuals, chronic granulocytic leukemia and acute hepatitis patients were found as the major form of occurrence, but dimethylbenzimidazolylcobamide coenzyme (DBCC) and hydroxocobalamin (OH-B
12) were slightly increased in serum and transcobalamin 1 from chronic granulocytic leukemia and acute hepatitis as compared with those from healthy individuals.
In transcobalamin 11 the proportion of occurrence of OH-B
12, DBCC, and CH
3-B
12 was considerably similar, but DBCC was relatively increased in transcobalamin 11 from acute hepatitis patients, suggesting that it is due to a release of DBCC from the liver.
Comparing the activities of
57Co in transcobalamins from sera of rats administered intracutaneously with 50 ng of CH
3-B
12-
57Co, DBCC-
57Co and CN-B
12-
57Co two hours before separating transcobalamins, there were no statistically significant differences in the uptake of cobalamins between transcobalamin 1 and transcobalamin 11.
View full abstract